SCHEMBL8245161

SCHEMBL8245161

C[C@H](CC(=O)O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGD P52209 1/20 0.37
SLC22A6 Q4U2R8 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
CACNA2D1 P54289 2/20 0.34
ADRA1A P35348 2/20 0.34
CACNB3 P54284 1/20 0.34
CACNA1C Q13936 1/20 0.34
PGR P06401 1/20 0.34
HTR2B P41595 1/20 0.34
CACNA2D2 Q9NY47 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
HMGCR P04035 1/20 0.33
CHRM1 P11229 1/20 0.33
TBXA2R P21731 1/20 0.33
ALOX15 P16050 1/20 0.32
MAPT P10636 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2873742 1.00 PGD (0.37) PGDSLC22A6TDP1CACNA2D1ADRA1A
SCHEMBL29139997 0.83 CACNA2D1 (0.34) PGDSLC22A6TDP1CACNA2D1ADRA1A
SCHEMBL19502229 0.79 MAPK1 (0.30) MAPK1
SCHEMBL30861202 0.79 LMNA (0.33) CHRM1MAPTTSHRMAPK1LMNA
SCHEMBL499939 0.79 ALDH1A1 (0.37) PGDSLC22A6TDP1CACNA2D1ADRA1A
SCHEMBL23128331 0.79 LMNA (0.33) CHRM1MAPTTSHRMAPK1LMNA
SCHEMBL25075958 0.79 ALDH1A1 (0.34) PGDSLC22A6TDP1CACNA2D1ADRA1A
SCHEMBL8822671 0.77 PGD (0.35) PGDSLC22A6TDP1CACNA2D1ADRA1A
SCHEMBL18327240 0.77 PGD (0.35) PGDSLC22A6TDP1CACNA2D1ADRA1A
SCHEMBL16478507 0.77 TSHR (0.39) MAPTCYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007064732-A1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND MICROBIAL DISEASES SCHERING CORPORATION (US) 2007-06-07 WO disclosed
WO-2007064749-A1 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS AND MICROBIAL DISEASES SCHERING CORPORATION (US) 2007-06-07 WO disclosed
WO-2005116009-A1 SUBSTITUTED 2-QUINOLYL-OXAZOLES USEFUL AS PDE4 INHIBITORS SCHERING CORPORATION (US) 2005-12-08 WO disclosed